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Proliferating eukaryotic cells possess checkpoint mechanisms that block cell division in
the presence of unreplicated or damaged DNA. Using cell-free extracts from Xenopus
eggs, we have investigated the mechanisms underlying the inability of a recombinant
Cdc2/cyclin B complex to induce mitosis in the presence of incompletely replicated
DNA. We found that the activities of the kinases and phosphatases that regulate the
major phosphorylation sites on Cdc2 (e.g., tyrosine 15, threonine 14, and threonine 161)
are not altered significantly under conditions where Xenopus extracts remain stably
arrested in interphase due to the presence of the replication inhibitor aphidicolin.
However, at threshold concentrations, a Cdc2/cyclin B complex containing a mutant
Cdc2 subunit that cannot be phosphorylated on either tyrosine 15 or threonine 14
displays a markedly reduced capacity to induce mitosis in the presence of aphidicolin.
This observation indicates that the replication checkpoint in Xenopus egg extracts func-
tions without the inhibitory tyrosine and threonine phosphorylation of Cdc2. We provide
evidence that the checkpoint-dependent suppression of the Cdc2/cyclin B complex
involves a titratable inhibitor that is regulated by the presence of unreplicated DNA.
INTRODUCTION
In dividing eukaryotic cells, a diverse family of cyclin-
dependent kinases (Cdks) directs the progression of
the cell cycle by regulating the accurate replication of
the genome during S-phase and the faithful segrega-
tion of the chromosomes at mitosis (M-phase). The
M-phase of the cell cycle is controlled by maturation
promoting factor (MPF), which contains a B-type cy-
clin and the Cdc2 protein kinase. MPF acts by phos-
phorylating a wide variety of substrates that collabo-
rate in the execution of mitotic processes such as
chromosome condensation, nuclear envelope break-
down, and spindle assembly (Nurse, 1990; Solomon,
1993; reviewed in Dunphy, 1994).
The action of MPF must be controlled both tempo-
rally and spatially in a very stringent manner. This
strict regulation is imparted by a number of check-
point mechanisms that operate during the preparation
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for mitosis (reviewed in Hartwell and Weinert, 1989;
Murray, 1992; Sheldrick and Carr, 1993). A key ques-
tion in the cell cycle field is how these checkpoint
mechanisms control the activation and/or action of
Cdks such as MPF so that cell cycle transitions occur
only when all essential prerequisites have been ful-
filled. In the case of M-phase, these requirements in-
clude the absence of unreplicated or damaged DNA,
the attainment of an adequate cell size for division,
and the accumulation of the various proteins neces-
sary for spindle assembly and other mitotic processes.
The activation of MPF is controlled by an intricate
series of phosphorylation reactions on the Cdc2 sub-
unit (reviewed in Fleig and Gould, 1991; Draetta, 1993;
Nigg, 1993; Pines, 1993; Solomon, 1993). Specifically,
phosphorylation of threonine residue 161 (T161) is
absolutely required for catalytic activity, but the effect
of this phosphorylation is overridden during inter-
phase by concomitant inhibitory phosphorylations on
tyrosine 15 (Y15) and threonine (T14). The tyrosine
phosphorylation and subsequent dephosphorylation
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of Cdc2 are mediated by the Weel and Cdc25 proteins,
respectively (Russell and Nurse, 1986, 1987; Dunphy
and Kumagai, 1991; Gautier et al., 1991; Parker and
Piwnica-Worms, 1992; McGowan and Russell, 1993).
In turn, the activities of both the Weel and Cdc25
proteins are controlled by upstream kinase/phos-
phatase networks, which themselves are highly regu-
lated so that tyrosine phosphorylation of Cdc2 is
strongly favored during interphase and dephosphory-
lation is rapidly triggered at mitosis (Solomon et al.,
1990; Izumi et al., 1992; Kumagai and Dunphy, 1992;
Clarke et al., 1993; Tang et al., 1993; Mueller et al., 1995).
It has appeared highly plausible that the phosphor-
ylation of Cdc2 on one or more of its key residues (e.g.,
Y15, T14, T161) would play a pivotal role in cell cycle
checkpoint mechanisms. For this reason, the role of
Cdc2-specific tyrosine phosphorylation in the opera-
tion of the replication checkpoint has been examined
in a number of systems, including fission yeast, bud-
ding yeast, and Xenopus eggs (Enoch and Nurse, 1990;
Lundgren et al., 1991; Amon et al., 1992; Enoch et al.,
1992; Smythe and Newport, 1992; Sorger and Murray,
1992; Mueller et al., 1995). However, these studies have
arrived at apparently contradictory conclusions. Sim-
ilarly, the roles of phosphorylation on T14 and T161 in
the replication checkpoint have not been resolved con-
clusively.
The Xenopus egg system offers many advantages for
the study of cell cycle-regulatory mechanisms. In par-
ticular, the progression of the cell cycle can be recon-
stituted in cytoplasmic extracts from Xenopus eggs,
and the replication checkpoint can be triggered in
vitro by addition of DNA synthesis inhibitors such as
aphidicolin (Dasso and Newport, 1990; Murray, 1991).
Normally, activated egg extracts synthesize cyclin B,
produce active MPF, and undergo mitosis in approx-
imately 1 h (Murray and Kirschner, 1989). However,
the addition of aphidicolin results in a prolonged ar-
rest in interphase (Dasso and Newport, 1990; Kumagai
and Dunphy, 1991; Smythe and Newport, 1992; Korn-
bluth et al., 1992, 1994). To date, the analysis of the
biochemical mechanisms underlying this checkpoint
has been hampered somewhat by the fact that aphidi-
colin-containing egg extracts arrest properly only with
endogenously synthesized cyclin B. Surprisingly, re-
combinant, bacterially expressed cyclin B induces mi-
tosis even in the presence of unreplicated DNA
(Smythe and Newport, 1992).
In this paper, we have developed an experimental
system in which Xenopus egg extracts containing ex-
ogenously added, baculovirus-expressed cyclin B and
Cdc2 proteins arrest properly in interphase due to the
addition of aphidicolin. Accordingly, we have been
able to comprehensively assess the effect of unrepli-
cated DNA upon the phosphorylation of Cdc2 protein.
The principal finding of these studies is that a Cdc2
mutant that cannot undergo phosphorylation on Y15
or T14 still responds to the replication checkpoint. We
present evidence for a titratable inhibitor that interacts
with the Cdc2/cyclin B complex in checkpoint-ar-
rested extracts.
MATERIALS AND METHODS
Production of Histidine-tagged Cyclin B and
ACyclin B
The human cyclin Bi cDNA (Pines and Hunter, 1989) was digested
with NcoI and BamHI and ligated with NcoI/BglII-digested
pVL1393-HIS6 (kindly provided by D. Morgan, University of Cali-
fornia at San Francisco, San Francisco, CA), thereby creating a
baculovirus transfer vector encoding the full-length cyclin B with
the extra amino acids MSHHHHHHGS at the N-terminal end. Trun-
cated, histidine-tagged human cycin B1 lacking the N-terminal 87
amino acids of the natural protein (Acyclin B) was prepared by
digesting the cDNA with KpnI, blunt-ending with T4 DNA poly-
merase, and ligating with an NcoI linker (CAGCCATGGCTG). The
resulting construct was cloned into pVL1393-HIS6 using the NcoI
and EcoRI sites. Recombinant baculoviruses encoding cyclin B and
Acyclin B were prepared by standard methods (Desai et al., 1992;
Coleman et al., 1993). Sf9 insect cells (60 ml at a density of 2 x 106
cells/ml) were infected with the baculoviruses for 48 h, washed
twice in ice-cold Tris buffered-saline (10 mM Tris-HCl, pH 7.5, 150
mM NaCl), and lysed in HBS (10mM HEPES-KOH, pH 7.5,150mM
NaCl) containing 5 mM ethylene glycol-bis(,-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA), 0.5% Triton X-100, 1 mM phenyl-
methylsulfonyl fluoride, and 10 ,ug/ml each of pepstatin, chymo-
statin, and leupeptin. The presence of EGTA in the lysis buffer
greatly reduced nonspecific binding to the nickel-IDA beads during
the purification of the histidine-tagged proteins (see below). The
lysate was centrifuged at 4°C for 20 min at 10 000 rpm in the Sorvall
HB-4 rotor. The resulting supernatant was incubated with 1 ml
nickel-IDA Sepharose Fast Flow (Pharmacia, Piscataway, NJ) at 4°C
for 30 min. The IDA Sepharose beads were charged with nickel
chloride according to the instructions of the manufacturer. The
cyclin-coated, nickel-IDA beads were washed successively with 50
volumes of HBS containing 0.5% NP-40 and 50 volumes of HBS. The
washed beads were aliquoted, frozen in liquid nitrogen, and stored
at -80'C.
Production of Wild-Type and Mutant Xenopus Cdc2
Proteins in Sf9 Insect Cells
Plasmids encoding various Xenopus Cdc2 mutant proteins (T161A,
T14A, Y15F, T14AY15F, and T14AY15FTI161A; Solomon et al., 1992)
were digested with NcoI and BanII. The resulting NcoI/BanII frag-
ments were ligated into pVL1393 encoding wild-type Xenopus Cdc2
(pVL1393-Cdc2; Coleman et al., 1993), which had been digested
previously with NcoI and BanII. This procedure created plasmids
encoding various Cdc2 mutants that lacked the hemagglutinin tag
provided by the original plasmids (Solomon et al., 1992). The Cdc2-
N133A mutant (containing the hemagglutinin tag) was prepared by
in vitro mutagenesis using the kit from Amersham and the oligo-
nucleotide GAAACCTCAGGCCCTCCTCATCG. The mutated
cDNA was cloned into pVL1393-Cdc2 that had been digested with
NcoI and PstI. Recombinant baculoviruses, prepared as described
above, were used to infect Sf9 insect cells. At 48 h post-infection, the
insect cells were washed twice with ice-cold Tris buffered saline and
resuspended in one-tenth of the original vol of a lysis buffer that
contained 10mM HEPES-KOH (pH 7.5), 10mM NaCl, 1 mM EGTA,
1 mM phenylmethylsulfonyl fluoride, and 10 ,ug/ml each of pep-
statin, chymostatin, and leupeptin. The cells were lysed by dounce
homogenization, NaCl was added to a final concentration of 150
mM, and the lysate was centrifuged at 4°C for 20 min at 10 000 rpm
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in the Sorvall HB-4 rotor. The supernatant was frozen in liquid
nitrogen and stored at -80°C.
Preparation of Various Cdc2/Cyclin B Complexes
Nickel-IDA agarose beads (25 ,ul) containing either cyclin B or
Acyclin B were incubated with 800 ,ul of Cdc2-containing Sf9 cell
lysate for 20 min either at 22°C in the presence of 0.5 mM ATP and
10mM MgCl2 or at 4°C in the absence of ATP and MgCl2. The beads
were washed four times with HBS and eluted in 50 j,l of 200 mM
imidazole in HBS. The isolated Cdc2/cyclin complex was used on
the same day it was prepared because it was not stable upon
freezing and thawing.
Preparation of Xenopus Egg Extracts
In all cases, CSF extracts from unactivated Xenopus eggs were pre-
pared as described previously (Murray, 1991; Kumagai and Dun-
phy, 1992; Tang et al., 1993). Typically, the extracts were activated by
the addition of 0.4 mM CaCl2 in the presence of 100 jig/ml cyclo-
heximide (which prevents endogenous cyclin B synthesis). Demem-
branated Xenopus sperm nuclei (up to 1000 per ,ul of egg extract)
were routinely added at the same time as CaCl2. Recombinant cyclin
B and Acycin B proteins (20-60 nM) were added at 50 min post-
activation when nuclear assembly around the sperm chromatin was
complete. Depending upon their final concentration, the cyclin pro-
teins induced mitosis in 30-60 min. The entry into mitosis was
monitored by visualizing nuclear envelope disassembly and chro-
mosome condensation by phase contrast and fluorescence micros-
copy (Kumagai and Dunphy, 1991; Murray, 1991). To block the
extracts in interphase caused by the presence of unreplicated DNA
(Dasso and Newport, 1990; Kornbluth et al., 1992), we added 100
,ug/ml aphidicolin (dissolved in DMSO at 10 mg/ml) to extracts
containing 1000 sperm nuclei per ,ul. Control extracts lacked aphidi-
colin, and contained 0-1000 sperm nuclei per ,ul and 1% DMSO. In
our experience, control extracts containing 0, 200, or 1000 nuclei per
,ul entered mitosis at comparable times because these extracts can
carry out the efficient replication of 4000 or more nuclei per ,ul in less
than 60 min. The aphidicolin-induced block to mitosis typically
persisted for 120-150 min after the addition of recombinant cyclin B
or Acyclin B. To overcome this block, caffeine (5 mM) or okadaic
acid (3 ,M) could be added in addition to aphidicolin.
In Vitro Phosphorylation of Cdc2 on T161
Nickel-IDA beads (10 ,ul) containing cyclin B were mixed with Sf9
insect cell lysates containing either wild-type Xenopus Cdc2 (200 ,lI
vol) or the Cdc2-N133A mutant (450 ,ul vol), and incubated at 4°C
for 20 min. The beads were centrifuged, the supernatant was re-
moved, and the beads were mixed with 50 ,lI of a fresh Cdc2-
containing lysate (either wild-type or mutant). The beads were then
incubated for 20 min at 22°C in the presence of 0.2 mCi 32P-ATP, 50
,tM nonradioactive ATP, and 10 mM MgCl2 to allow the phosphor-
ylation of Xenopus Cdc2 on T161 due to the action of a Cdk-
activating kinase (CAK) present in Sf9 cell lysates. No detectable
phosphorylation of T14 or Y15 occurs under these conditions. After
the incubation, the beads were washed with HBS (five times) and
eluted in 20 ,ul of HBS containing 200 mM imidazole.
Assay for Total Cdc2-specific Tyrosine Kinase
Activity
The Acyclin B protein (40 nM, final concentration) was added to
cycloheximide-containing interphase extracts 50 min after activation
with calcium. At various times thereafter, 100 Il aliquots were
removed, chilled on ice, and then mixed with 20 ,1. of nickel-IDA
agarose beads. The beads were incubated with the extract for 10 min
on ice, then washed successively with HBS containing 0.1 mM
sodium vanadate (once) and HBS alone (twice). Bead-associated
proteins were then eluted with sodium dodecyl sulfate (SDS) gel
sample buffer, electrophoresed in 10% polyacrylamide gel, and fi-
nally subjected to immunoblotting with anti-phosphotyrosine or
anti-Xenopus Cdc2 antibodies. For the Cdc2-specific tyrosine kinase
assays presented in this paper, we did not find it necessary to
include sodium vanadate as an inhibitor of Cdc25 activity, which is
low during interphase. However, similar results were obtained in
the presence of sodium vanadate (our unpublished observation).
Also, for the tyrosine kinase assays described in this paper, we
verified that the aphidicolin-treated extracts remained arrested in
interphase for the duration of the experiment.
Radiolabeling of Xenopus Cdc2 on Y15
The Cdc2/cyclin B complex (8 ,ul vol) was prepared as described
above and mixed with the Xenopus Weel protein (10 ng; Mueller et
al., 1995) in 40 ,lI of 50 mM Tris-HCl (pH 7.5) containing 10 mM
MgCl2, 1 mM DTT, and 40 ,uCi of 32P-ATP. After a 30-min incuba-
tion at 22°C, the reaction was terminated by incubating for an
additional 20 min at 37°C (which results in the thermal inactivation
of the Xenopus Weel protein). The Cdc2/cyclin B complex was
re-isolated with 15 ,ul of nickel-IDA beads and eluted in 40 ,ld of 200
mM imidazole in HBS.
35S-Labeling of the Xenopus Cdc2 Protein in Sf9
Insect Cells
Sf9 insect cells (10 ml at 2 x 106 cells per ml) were infected with the
Xenopus Cdc2-encoding baculovirus for 40 h in complete TNM-FH
medium (Invitrogen, San Diego, CA). The cells were rinsed twice
with methionine-free Grace's medium (Life Technologies, Inc.,
Gaithersburg, MD), and incubated for 7 h in 2.5 ml of the same
medium containing 10% dialyzed fetal calf serum and 0.5 mCi of
35S-Translabel (ICN, Cleveland, OH). The cells were lysed and a
35S-Cdc2/cycin B complex was prepared as described above.
32P-Labeling of the Cdc2/Cyclin B Complex in
Xenopus Egg Extracts
A CSF extract (300 ,lI vol) was activated in the presence of 100
,Lg/ml cycloheximide by the addition of 0.4 mM CaCl2 and incu-
bated for 50 min at 22°C with 2 mCi of 32P-orthophosphate (ICN). At
this time, 20 nM of cyclin B was added and the incubation was
continued for 10 min. The extract was chilled on ice, mixed with
nickel-IDA beads (10 ,il), incubated for 30 min at 4°C under constant
agitation, and spun in a microfuge E (Beckman Instruments, Palo
Alto, CA) for 5 sec. The beads were washed as follows: once with
extraction buffer (80 mM sodium B3-glycerolphosphate, pH 7.3, 20
mM EGTA, and 15 mM MgCl2) containing 0.5% NP-40, 1 mM
sodium vanadate, 1 ,LM microcystin, and 10 ,uM each of phospho-
tyrosine, phosphothreonine, and phosphoserine; five times with
extraction buffer containing 0.5% NP-40; twice with HBS; and finally
twice with HBS containing 25 mM imidazole. Bound proteins were
eluted in HBS containing 250 mM imidazole, electrophoresed in a
10% polyacrylamide gel, and visualized with x-ray film. Bands
corresponding to the Cdc2 and cyclin B proteins were processed for
phosphoamino acid analysis and tryptic phosphopeptide mapping
as described previously (Boyle et al., 1991).
Purification of the Cdc2-AFIACyclin B Complex by
Gel Filtration Chromatography
Nickel-IDA beads (50 ,ul) containing Acycin B were mixed with Sf9
cell lysate (1.2 ml) containing the Xenopus Cdc2-AF mutant protein.
The beads were incubated for 30 min at 4°C under constant agita-
tion, centrifuged, and mixed with an additional 1.2 ml of the mutant
Cdc2-containing lysate. At this point, the beads were incubated for
20 min at 22°C in the presence of 0.5 mM ATP and 10 mM MgCl2.
Finally, the beads were washed four times with HBS and eluted in
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50 ,ul of HBS containing 300mM imidazole. The eluted complex was
chromatographed using a SMART system (Pharmacia) on a Super-
dex 200 PC column equilibrated in 10 mM HEPES-KOH (pH 7.5)
containing 150 mM NaCl. Fractions (50 ,ul vol) were collected at 4°C.
Under these conditions, free Acyclin B not associated with Cdc2
migrated as an oligomer in the void volume, whereas the dimeric
Cdc2/cycin B complex eluted at a position corresponding to -100
kDa. A complex between Acyclin B and the Cdc2-T14AY15FT161A
mutant was prepared in a similar manner.
A
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Miscellaneous
HI kinase assays were performed as described previously (Dunphy
and Newport, 1989). [,y-32P]ATP (3000 Ci/mmol) for kinase assays
was purchased from ICN. Affinity-purified antibodies against the
bacterially expressed Xenopus Cdc2 protein (Milarski et al., 1991)
were prepared by established procedures (Kumagai and Dunphy,
1992). Antibodies against human cyclin BI and phosphotyrosine
were obtained from Upstate Biotechnology (UBI, Lake Placid, NY).
Immunoblotting was performed as described previously (Coleman
et al., 1993) with 1251-protein A (ICN) or 251I-sheep anti-mouse anti-
bodies (Amersham, Arlington Heights, IL). In some cases, SDS gel
electrophoresis was performed with 10% polyacrylamide gels con-
taining 0.4% PDA (piperadine diacrylamide; Bio-Rad, Richmond,
CA) instead of 0.26% bisacrylamide to enhance the separation of
various phosphorylated forms of the Cdc2 protein. Detection and
quantitation of immunoblots was performed with a PhosphorIm-
ager (Molecular Dynamics, Sunnyvale, CA).
RESULTS
Preparation of Recombinant Cyclin B that Responds
to the Replication Checkpoint in the Xenopus
System
To study the mechanism by which unreplicated DNA
inhibits mitosis in Xenopus egg extracts, we attempted
to establish an experimental system in which an
exogenously added, recombinant cyclin B or Cdc2/
cyclin B complex would be prevented from inducing
M-phase in the presence of a DNA synthesis inhib-
itor (e.g., aphidicolin). We found that cyclin B and
Cdc2 proteins that had been expressed in baculovi-
rus-infected Sf9 insect cells were suitable for this
purpose. For the studies reported in this paper, we
prepared histidine-tagged versions of both the full-
length human cyclin Bi and a truncated, nonde-
gradable mutant cyclin Bi that lacks a destruction
box (Pines and Hunter, 1989; Glotzer et al., 1991).
These proteins, which we will refer to as cyclin B
and Acyclin B, were purified by a modified proce-
dure for nickel-IDA agarose chromatography that
greatly reduced nonspecific binding to the nickel
beads (see MATERIALS AND METHODS). Using
this improved protocol, it was possible to obtain
highly purified cyclin B or Acyclin B in a single
step (Figure 1A, lanes c and d). In parallel, we
prepared in Sf9 cells the intact Xenopus Cdc2 protein
and a variety of mutant Cdc2 proteins that lack key
phosphorylatable residues, including the Cdc2-
T14AY15F mutant (Cdc2-AF) in which T14 and Y15
have been mutated to alanine and phenylalanine,
respectively (Solomon et al., 1992; see MATERIALS
- cyclin B





Figure 1. Preparation of baculovirus-expressed cyclin B and Cdc2
proteins. (A) Purification of the Cdc2/cyclin B complex. Nickel-IDA
beads containing human cyclin BI (lane c) were added to Sf9 insect
cell lysates containing the intact Xenopus Cdc2 protein in the pres-
ence of 0.5 mM ATP and 10 mM MgCl2 at 22°C (lane b) or in the
absence of ATP and MgCl2 at 4'C (lane a). The beads were washed
with HBS and eluted with 150 mM imidazole as described in
MATERIALS AND METHODS. Lane d depicts Acyclin B that was
purified similarly with nickel-IDA beads. The eluted complexes
were subjected to gel electrophoresis and Coomassie blue staining.
(B) HI kinase activity of the recombinant Cdc2/cycin B complex.
The Cdc2/cyclin B (lanes a and b) and Cdc2/Acyclin B (lanes c and
d) complexes that were prepared in the absence (lanes a and c) or
presence (lanes b and d) of ATP were assayed for HI kinase activity
as described in MATERIALS AND METHODS. (C) The HI kinase
activity of a complex between cycin B and either wild-type Xenopus
Cdc2 (lane a) or the Cdc2-AF mutant (lane b) was determined as in
panel B.
AND METHODS). The intact and mutant forms of
Cdc2 were purified from insect cell lysates by virtue
of their ability to bind to cyclin B-coated nickel
agarose beads.
We prepared either the inactive or active Cdc2/
cyclin B complex for the studies described in this
paper. Fortuitously, Sf9 insect cells contain an endog-
enous CAK that efficiently phosphorylates Xenopus
Cdc2 on T161 if binding to cyclin is allowed to occur at
22°C in the presence of MgCl2 and ATP (see Desai et
al., 1992). As shown in Figure 1, a highly purified
Cdc2/cyclin B complex in which the Cdc2 subunit was
phosphorylated on T161, as judged by a downward
mobility shift during gel electrophoresis, was highly
active as an Hi kinase (Figure 1A, lane b; Figure 1B,
lane b). Control experiments with the Cdc2-T161A
mutant confirmed that this down-shifting was due to
phosphorylation on T161 (our unpublished observa-
tion). In contrast, when the Cdc2/cyclin B complex
was allowed to form at 4°C, it lacked T161 phosphor-
ylation and was inactive (Figure 1A, lane a; Figure 1B,
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lane a). Using the same protocol with isolated Acyclin
B (Figure 1A, lane d), we also purified either the
inactive or active Cdc2/Acyclin B complex (Figure 1B,
lanes c and d). Finally, for many experiments in this
paper, we prepared a complex between cyclin B and
the Cdc2-AF mutant, which displayed a level of Hi
kinase activity similar to the wild-type Cdc2/cyclin B
complex (Figure 1C, lanes a and b).
Both recombinant cyclin B and Acyclin B, either
alone or in a complex with Cdc2, induced mitosis
efficiently, as judged by their ability to elicit both
nuclear envelope breakdown and stimulation of Cdc2-
associated Hi kinase activity (Figure 2, A and C,
closed circles; Figure 2B, lanes a-e). The minimal ef-
fective concentrations of cyclin B and Acyclin B for
mitotic induction were 20 nM and 16 nM, respectively
(see Kobayashi et al., 1991). In contrast, neither the
full-length nor the Acyclin B proteins at equivalent or
considerably higher concentrations (up to 60 nM)
could induce mitosis in extracts that contained the
DNA synthesis inhibitor aphidicolin. In such extracts,
the recombinant cyclins failed to trigger both nuclear
disassembly and activation of Cdc2, typically for at
least 120 min after addition to the extract (Figure 2, A
and C, closed triangles; Figure 2B, lanes f-j). As a
control, we added caffeine, a drug that is known to
override the inhibition of mitosis by unreplicated
DNA in both tissue culture cells and Xenopus egg
extracts (Schlegel and Pardee, 1987; Dasso and New-
port, 1990). We observed that caffeine could overcome
the inhibitory effect of aphidicolin (Figure 2A, open
triangles). Likewise, the addition of 3 ,uM okadaic acid
could reverse the aphidicolin-induced block to mitosis
(our unpublished observation).
In summary, the recombinant cyclin B and Acyclin B
proteins that we prepared for this paper induce mito-
sis efficiently at physiological concentrations. Both cy-
clin proteins are stable during interphase, and the
Acyclin B protein is also stable during mitosis (see
Figure 2A, closed circles). As expected, the full-length
cyclin B protein is degraded during mitosis (see Figure
2C, closed circles), indicating that the presence of the
histidine tag does not interfere with ubiquitin-medi-
ated proteolysis. Most importantly, neither cyclin pro-
tein can induce mitosis in the presence of unreplicated
DNA, indicating that these polypeptides obey a repli-
cation checkpoint that operates in the cell cycle ex-
tracts.
Total Cdc2-specific Tyrosine Kinase Activity in
Checkpoint-arrested Extracts
Using both the recombinant cyclin B and Cdc2 pro-
teins, we set out to assess the effect of unreplicated
DNA upon the regulation of the enzymes that control
phosphorylation at key residues on the Cdc2 protein.
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Figure 2. The recombinant cyclin B and Cdc2 proteins cannot
induce mitosis in the presence of unreplicated DNA. (A) Purified
Acyclin B (32 nM) was added to cycloheximide-containing inter-
phase egg extracts in the presence of: 200 demembranated Xenopus
sperm nuclei per ,ul of extract (closed circles); 1000 nuclei per ,ul
and 100 jig/ml aphidicolin (closed triangles); or 1000 nuclei per
,ul, 100 /Lg/ml aphidicolin, and 5 mM caffeine (open triangles). At
the indicated times after the addition of cyclin (t = 0), the
percentage of nuclear envelope breakdown (NEB) in the extracts
was determined. APC, aphidicolin; CAFF, caffeine. (B) The puri-
fied, inactive Cdc2/cyclin B complex (32 nM) was added to
interphase extracts containing 200 nuclei per ,ul (lanes a-e) or
1000 nuclei per p.l and 100 jig/ml aphidicolin (lanes f-j). Aliquots
were removed for HI kinase assays at the following times after
the addition of the complex: 0 min (a, f); 10 min (b, g); 20 min (c,
h); 30 min (d, i); and 40 min (e, j). (C) Quantitation of the data in
panel B (in arbitrary units).
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under the control of the replication checkpoint, so it
was feasible to prepare reliable substrates for these
Cdc2 phosphorylation assays.
The phosphorylation of Cdc2 on tyrosine 15 plays
an important role in mitotic control in a variety of
organisms (Russell and Nurse, 1987; Dunphy and
Newport, 1989; Gould and Nurse, 1989; Morla et al.,
1989; Solomon et al., 1990; Krek and Nigg, 1991;
McGowan and Russell, 1993). To measure total Cdc2-
specific tyrosine kinase activity in the Xenopus egg
system, we added recombinant Acyclin B to egg ex-
tracts, isolated the resulting Cdc2/Acyclin B complex
at successive intervals by chromatography on nickel-
IDA agarose, and finally measured tyrosine phosphor-
ylation of Cdc2 by immunoblotting with anti-phos-
photyrosine antibodies (Figure 3, A and B). There was
A
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a linear increase with respect to time in the phospho-
tyrosine content of Cdc2 as the Cdc2/cyclin B complex
formed in control interphase extracts (Figure 3A, lanes
d-g; Figure 3B, open circles). However, the rate of
Cdc2-specific tyrosine phosphorylation did not
change in the presence of aphidicolin (Figure 3A, lanes
h-k; Figure 3B, closed circles). Moreover, the presence
of caffeine in addition to aphidicolin also had no effect
on Cdc2-specific tyrosine kinase activity (Figure 3A,
lanes l-o; Figure 3B, closed triangles). In contrast, the
tyrosine phosphorylation of Cdc2 was greatly dimin-
ished in M-phase extracts (Figure 3A, lanes a-c; Figure
3B, open triangles), indicating that this assay was suit-
able for detecting the expected reduction of total
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Figure 3. Cdc2-specific tyrosine kinase activity in aphidicolin-containing Xenopus egg extracts. (A) The Acyclin B protein (32 nM) was added
either to M-phase extracts (lanes a-c) or to interphase extracts containing: no nuclei (lanes d-g); 1000 nuclei per ,ll and 100 ,ug/ml aphidicolin
(lanes h-k); or 1000 nuclei per ,ul, 100 u.g/ml aphidicolin, and 5 mM caffeine (lanes l-o). At the indicated times (in minutes), the resulting
Cdc2//cyclin B complexes were isolated by nickel-IDA chromatography and subjected to immunoblotting with either anti-phosphotyrosine
(top panel) or anti-Cdc2 (bottom panel) antibodies. (B) Quantitation of the phosphotyrosine content of the Cdc2 protein from the data in panel
A (in arbitrary units). The data were normalized to the amount of Cdc2 protein associated with cyclin at each time point, as determined by
immunoblotting with anti-Cdc2 antibodies. (C) The active Cdc2/cyclin B complex was radiolabeled with 32P on T161 as described in
MATERIALS AND METHODS, and added to the following extracts: M-phase (lanes a-c); interphase lacking aphidicolin (lanes d-h);
interphase containing aphidicolin (lanes i-m); or interphase containing aphidicolin and caffeine (n-r). At the indicated times, aliquots were
removed for electrophoresis and phosphorimaging. Lane s depicts the unincubated complex. (D) A complex between cyclin B and the
kinase-negative Cdc2-N133A mutant that was labeled on T161 was prepared as in panel C, and added to extracts that either lacked (lanes
a-e) or contained (lanes f-j) aphidicolin. Aliquots were removed at the indicated times and processed as described in panel C. Lane k depicts
the unincubated complex.
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lomon et al., 1990; Smythe and Newport, 1992; Tang et
al., 1993; Mueller et al., 1995).
To obtain an independent measure of Cdc2-specific
tyrosine kinase activity, we also added a pre-formed
Cdc2/cyclin B complex to the Xenopus extracts. In
particular, we prepared a Cdc2/cyclin B complex that
was specifically labeled with 32p on T161 as described
in MATERIALS AND METHODS. Upon the addition
of this complex to egg extracts, the labeled Cdc2 pro-
tein underwent phosphorylation on both Y15 and T14,
as judged by an upward mobility shift that could be
detected after gel electrophoresis (Figure 3C). As a
control, we demonstrated that the Cdc2-AF mutant
did not undergo this phosphorylation-dependent mo-
bility shift (our unpublished observation). Using this
method, we determined that neither unreplicated
DNA nor caffeine affected the rate at which the labeled
Cdc2 protein was converted to its tyrosine phosphor-
ylated form (Figure 3C, lanes d-s; note that tyrosine
kinase activity is reduced in M-phase, lanes a-c). Fi-
nally, to rule out the possibility that the addition of
small amounts of active Cdc2/cyclin B complex might
perturb the accurate measurement of tyrosine kinase
activity, we also prepared a complex of cyclin B and
the kinase-negative Cdc2-N133A mutant (Connell-
Crowley et al., 1993). The Cdc2 subunit of this complex
was radiolabeled with 32p on T161, and then added to
interphase extracts in the absence and presence of
aphidicolin (Figure 3D). Consistent with the results
described above, there was no apparent effect of un-
replicated DNA upon the rate at which this catalyti-
cally-inactive Cdc2 protein was converted to its ty-
rosine-phosphorylated form (Figure 3D, compare
lanes a-e with lanes f-j). In conclusion, using three
different assay methods, we found that total Cdc2-
specific tyrosine kinase activity was unaffected by the
presence of unreplicated DNA.
Total Cdc2-specific Tyrosine Phosphatase Activity
in Checkpoint-arrested Extracts
Previous studies in which the C-type Cdc25 protein
was immunoprecipitated from Xenopus extracts and
assayed for Cdc2-specific tyrosine phosphatase activ-
ity indicated that the presence of unreplicated DNA
did not affect the steady state activity of Cdc25 during
interphase (Izumi et al., 1992; Kumagai and Dunphy,
1992). However, it is conceivable that these assays did
not detect other potential classes of the Cdc25 protein
besides the C-type that might be important for mitotic
induction (Galaktionov and Beach, 1991). Therefore,
we felt that it would be worthwhile to perform in situ
measurements of total Cdc2-specific tyrosine phos-
phatase activity in Xenopus extracts using the baculo-
virus-expressed Cdc2/cyclin B complex as the sub-
strate. For this purpose, we prepared a Cdc2/cyclin B
complex that was specifically labeled with radioactive
phosphate on Y15 by treatment with a Xenopus Weel-
like tyrosine kinase (see MATERIALS AND METH-
ODS). Upon addition of this radiolabeled complex to
Figure 4. Rates of total Cdc2-
specific tyrosine phosphatase ac-
tivity in cycling and checkpoint-
arrested Xenopus egg extracts. (A)
A complex between cyclin B and
recombinant Xenopus Cdc2 pro-
tein that was radiolabeled with
32p specifically on Y15 by treat-
ment with Xenopus Weel tyrosine
kinase was purified as described
in MATERIALS AND METHODS.
The 32P-labeled Cdc2/cyclin B
complex was added to M-phase ex-
tracts (lanes a-e) or interphase ex-
tracts containing: no nuclei (lanes
f-j); 1000 nuclei per ,ul of egg extract
and 100 gg/ml aphidicolin (lanes
k-o); or 1000 nuclei per ,ul, 100
,Lg/ml aphidicolin, and 5 mM caf-
feine (lanes p-t). At the indicated
times (in minutes), aliquots were
removed and electrophoresed in a
10% polyacrylamide-PDA gel. The
arrowheads denote the Y15-singly
phosphorylated (bottom) and
T14Y15-doubly phosphorylated
(top) forms of the Cdc2 protein. (B)
Quantitation of the rates of tyrosine
dephosphorylation of the 32P-la-
beled Cdc2 protein shown in panel
A.
A a b c d e f g h j k m n o p q r s t
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Xenopus extracts, we observed that the 32P-phosphate
on Y15 was relatively stable in interphase extracts
(Figure 4A, lanes f-t; Figure 4B), as would be expected
(Solomon et al., 1990; Izumi et al., 1992; Kumagai and
Dunphy, 1992). In contrast, the Y15 site was dephos-
phorylated with a rapid half-time of approximately 4
min in M-phase extracts (Figure 4A, lanes a-e; Figure
4B, open triangles), consistent with earlier studies.
However, the rate of tyrosine dephosphorylation dur-
ing interphase was essentially identical in extracts that
either lacked or contained aphidicolin (Figure 4A,
lanes f-o; Figure 4B), or contained both caffeine and
aphidicolin (Figure 4A, lanes p-t; Figure 4B). There-
fore, using a recombinant Cdc2/cyclin B complex that
comes under the control of a replication checkpoint in
Xenopus extracts, we detected no direct modulation of
total Cdc25-mediated tyrosine phosphatase activity in
the presence of unreplicated DNA.
During these experiments, we observed that the
Cdc2 protein that was radiolabeled solely on Y15 un-
derwent an additional phosphorylation upon incuba-
tion in the interphase extracts, which could be ob-
served as an upward mobility shift during SDS gel
electrophoresis (Figure 4A). Because this shift did not
occur if the T14A mutant of Cdc2 was exchanged for
the wild-type Cdc2 protein (our unpublished observa-
tion), we attribute this mobility shift to phosphoryla-
tion on T14. Significantly, by this assay method, we
could observe no difference in the rate of T14 phos-
phorylation between extracts that contained aphidico-
lin and comparable extracts that either lacked aphidi-
colin or contained both caffeine and aphidicolin
(Figure 4A, lanes f-t; the top and bottom arrows de-
note the T14/Y15 doubly phosphorylated and Y15
singly phosphorylated forms of Cdc2, respectively).
This experiment suggests that T14-specific kinase ac-
tivity is not up-regulated in the presence of unrepli-
cated DNA, at least as measured by the ability of this
kinase to act upon Cdc2 that had been phosphorylated
previously on Y15.
Rates of T161 Phosphorylation and
Dephosphorylation in Checkpoint-arrested Extracts
It is well established that phosphorylation of Cdc2 on
T161 is essential for its catalytic activity. To examine
the possibility that phosphorylation of T161 might be
affected in the presence of unreplicated DNA, we pre-
pared a complex between cyclin B and the 35S-labeled
T14AY15F mutant of Cdc2 that can be phosphorylated
only on T161 (Figure 5). Upon addition of this com-
plex to Xenopus egg extracts, the phosphorylation of
the radiolabeled Cdc2 protein on T161 could be de-
tected as a downward mobility shift during gel elec-
trophoresis (Figure 5A). Because the dephosphoryla-
tion of T161 occurs very slowly in interphase extracts
(Lee et al., 1994; see Figure 6), this assay detects the
rate of T161 phosphorylation selectively. We observed
that T161 phosphorylation in Xenopus extracts oc-
curred rapidly with a half-time of approximately 1
min, but this rate did not vary depending upon the
presence of unreplicated DNA or caffeine (Figure 5A,
A
a b c d e f g h j k m n o p q s t






0 15 30 60 120 Q 15 30 60 120 0 15 30 60 120
- APC + APC + CAFF
Figure 5. The rate of T161
phosphorylation is not af-
fected in aphidicolin-treated
extracts. (A) A complex be-
tween cyclin B and 35-labeled
sec Cdc2-AF protein was purified
as described in MATERIALS
AND METHODS. The 35S-la-
beled complex was added to
M-phase extracts (lanes a-e) or
to interphase extracts contain-
ing: no nuclei (lanes f-j); 1000
nuclei per ,ul of extract and 100
,ug/ml aphidicolin (lanes k-o);
or 1000 nuclei per ,ul, 100jig/ml aphidicolin, and 5 mM
caffeine (lanes p-t). At the in-
dicated times (in seconds),
aliquots were subjected to
SDS electrophoresis in a 10%
polyacrylamide-PDA gel. (B)
Quantitation of the data in A.
Symbols are the same as in
Figure 4.
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Figure6. TherateofT161 dephospho- a b c d e f g h j k m n o p q r
rylation is not accelerated in Xenopus
egg extracts arrested in S-phase. A com-
plex between cyclin B and the Cdc2-AF
protein that was radiolabeled with 32p 32
on T161 was purified as described in
MATERIALS AND METHODS. The
32P-labeled complex was added either to
M-phase extracts (lanes a-c) or to inter- 0 4 16 0 2 4 8 16 0 2 4 8 16 Q 2 4 8 16phase extracts containing: no nuclei M-phase APC8 APC + CAFF(lanes d-h); 1000 nuclei per ,lI of egg
extract and 100 ,ug/ml aphidicolin (lanes i-m); or 1000 nuclei per ,ul, 100 ,ug/ml aphidicolin, and 5 mM caffeine (lanes n-r). At the indicated
times (in minutes), aliquots were removed for electrophoresis in a 10% polyacrylamide-PDA gel.
lanes f-t; Figure 5B). Moreover, consistent with earlier
reports (Solomon et al., 1992; Brown et al., 1994; Lee et
al., 1994), the rate of T161 phosphorylation was the
same during both interphase and mitosis (Figure 5A,
lanes a-j; Figure 5B).
Acting in opposition to CAK is an unknown phos-
phatase that dephosphorylates T161. To measure the
activity of the T161-specific phosphatase, we prepared
a 32P-labeled Cdc2/cyclin B complex in which Cdc2
was phosphorylated specifically on T161 as described
in MATERIALS AND METHODS. Upon the addition
of this substrate to interphase egg extracts, the 32P_
labeled phosphate group was quite stable whether or
not the extracts contained unreplicated DNA (Figure
6). Specifically, the phosphate levels on Cdc2 re-
mained relatively constant for at least 16 min in inter-
phase extracts that either lacked or contained aphidi-
colin (Figure 6, lanes d-m). Likewise, the presence of
caffeine in addition to aphidicolin had no effect on
T161 dephosphorylation (Figure 6, lanes n-r). In con-
trast, there was significant dephosphorylation of T161
in an M-phase extract by the latest time point (16 min;
Figure 6, lane c), which corresponded to the time by
which substantial degradation of cyclin B had oc-
curred (our unpublished observation). Therefore, al-
though this assay method can readily detect dephos-
phorylation of T161 when cyclin is degraded in mitotic
extracts (Lorca et al., 1992), the presence of unrepli-
cated DNA has no effect upon this phosphatase activ-
ity. Collectively, these results suggest that neither
phosphorylation nor dephosphorylation of T161 can
account for the inability of Cdc2 to induce mitosis in
the checkpoint-arrested extracts.
Unreplicated DNA Inhibits the Capacity of the
Cdc2-AF Mutant to Induce Mitosis
The above results indicate that the inability of Cdc2/
cyclin B to trigger mitosis in the presence of a DNA
synthesis inhibitor cannot be explained solely on the
basis of the stimulation or inhibition of the enzymes
that regulate phosphorylation at known sites on the
Cdc2 protein. Moreover, we demonstrated by tryptic
phosphopeptide mapping that the overall phosphor-
ylation pattern of Cdc2 was very similar in the pres-
ence and absence of aphidicolin (Figure 7, compare
panels A and B), arguing against the involvement of
novel phosphorylation sites. One prediction of these
findings is that a Cdc2/cyclin B complex in which
the Cdc2 subunit cannot be phosphorylated on Y15
or T14 also would be unable to induce mitosis in the
presence of incompletely replicated DNA. To test
this possibility, we prepared a complex between
Acyclin B and the Cdc2-AF protein as described
above, except with the modification that the com-
plex was purified further by gel filtration chroma-
tography on a Superdex 200 PC column. This pro-
cedure allowed us to prepare a complex containing
equimolar amounts of the Acyclin and Cdc2-AF pro-
teins that migrated with an apparent size of 100 kDa
on the gel filtration column (see silver-stained gel of
a typical preparation in Figure 8A). For these exper-
iments, we prepared the catalytically active complex
by allowing T161 phosphorylation of Cdc2 to occur
before purification of the complex. In addition, we
used only the Acyclin B protein in these experiments
because of a poor recovery of the full-length cyclin
B/Cdc2 complex from the Superdex column.
As expected, the purified Acyclin B/Cdc2-AF com-
plex induced mitosis efficiently in cycloheximide-con-
taining extracts that lacked aphidicolin (Figure 8C,
closed squares in panels a, b, and c). The Acyclin
B/Cdc2-AF complex was very potent as a mitotic
inducer: concentrations of 4 nM or greater were suffi-
cient to trigger nuclear disassembly in the egg extracts.
For comparison, it was necessary to add 16 nM of the
isolated Acyclin B protein to elicit mitosis.
In parallel, we added the Acyclin/Cdc2-AF complex
to aphidicolin-containing extracts. Significantly, there
was a pronounced delay in the rate at which the
Cdc2-AF protein could induce mitosis in these extracts
relative to the control extracts, which lacked aphidi-
colin (Figure 8C, closed circles in panels a, b, and c).
This aphidicolin-dependent delay varied with the
amount of added Acyclin/Cdc2-AF complex. At the
threshold concentration that was sufficient to induce
mitosis in a control extract, there was no nuclear en-
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maps of the Cdc2 protein in the
absence and presence of un-
replicated DNA. The cyclin B
protein (32 nM) was added to
interphase extracts that had
been pre-incubated with 32p_
orthophosphate. The extracts
contained either no added nu-
clei (A) or 1000 nuclei per ,ul
and 100 ,ug/ml aphidicolin (B).
The peptides are phosphory-
lated on: T14 and Y15 (spot 1);
Y15 alone (spot 2); or T161
(spot 3).
velope breakdown in the aphidicolin-containing ex-
tract, even after 120 min. At an intermediate con-
centration of Acyclin/Cdc2-AF complex, there was
only partial nuclear envelope breakdown (-30 to
40% of total) at 120 min, whereas nuclear disassem-
bly was complete by 60 min in the control extract.
Interestingly, the nuclei that did not break down in
this incubation (60-70% of total) showed no indica-
tion that active Cdc2 might be present. In particular,
the chromatin displayed no signs of mitotic conden-
sation, and the nuclear envelope appeared fully in-
tact by phase contrast microscopy (our unpublished
observation). Finally, at the highest concentration of
added complex in this experiment, there was still an
obvious delay of approximately 20 min in the onset
of mitosis in the aphidicolin-treated extract. In con-
trol experiments with 35S-labeled Cdc2-AF protein,
we showed that the Cdc2-AF protein remained sta-
bly associated with Acyclin B under these conditions
(Figure 8B, lanes c and d). Moreover, the Cdc2-AF
protein in the aphidicolin-containing extract was
present mainly in the T161-phosphorylated form
(Figure 8B, lane d), as was the case in the control
extract (Figure 8B, lane c).
To further characterize the reduced capacity of the
Cdc2-AF protein to elicit mitosis in the presence of
unreplicated DNA, we utilized drugs that override the
replication checkpoint. We observed that the addition
of caffeine could abrogate the inhibitory affect of
aphidicolin upon the ability of the Cdc2-AF/Acyclin B
complex to trigger nuclear envelope disassembly (Fig-
ure 9A). Similarly, 3 ,tM okadaic acid could reverse
the effect of aphidicolin upon the Cdc2-AF protein
(our unpublished observation).
Next, we examined the Hi kinase activity of the
Cdc2-AF/Acyclin B after re-isolation from the extracts
containing unreplicated DNA. For this purpose, we
added the complex to extracts in the absence and
presence of aphidicolin, re-isolated the complex with
nickel-IDA beads, and measured Cdc2-associated Hi
kinase activity (Figure 9B). Under these particular con-
ditions, the Cdc2-AF/Acyclin B complex isolated from
the aphidicolin-containing extracts displayed an Hi
kinase activity comparable to complexes that had been
incubated either in the absence of aphidicolin or in the
presence of both aphidicolin and okadaic acid (Figure
9B, lanes d-i). One interpretation of this observation is
that the Cdc2-AF/Acyclin B complex might have dis-
sociated from an inhibitor during re-isolation of the
soluble complex from the aphidicolin-containing ex-
tracts.
To evaluate this possibility, we asked whether a
catalytically inert Cdc2/cyclin B complex could over-
ride the aphidicolin-dependent block to mitosis by
acting as a competitor for the putative inhibitor (Fig-
ure 10). For this purpose, we utilized the Cdc2-
T14AY15FTI161A mutant (Cdc2-AFA), which cannot
be phosphorylated on T14, Y15, and T161. In partic-
ular, we purified a complex between this triple mu-
tant of Cdc2 and the Acyclin B protein on a Super-
dex 200 PC column. Then, we added this mutant
complex to an aphidicolin-containing extract that
lacked cycloheximide and hence accumulated an
endogenous, inactive Cdc2/cyclin B complex. The
triply-mutated Cdc2 must always remain inactive as
a kinase, so it normally cannot induce mitosis. How-
ever, upon addition to the aphidicolin-treated ex-
tracts, the recombinant Cdc2-AFA/Acyclin B com-
plex (10 nM) efficiently reversed the inhibition of
mitosis (Figure 10, compare open and closed cir-
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Figure 8. The Cdc2-AF
mutant cannot induce mito-
sis efficiently in aphidicolin-
containing extracts. (A) A
complex between Acycin B
and the Cdc2-AF mutant
was purified by gel filtration
on a SMART Superdex 200
PC column. Aliquots of the
column fractions were sub-
jected to gel electrophoresis
and silver staining. The peak
fraction of the complex is de-
picted. (B) The Cdc2-AF/
Acycin B complex is stable
in egg extracts. A complex in
which the Cdc2 subunit was
radiolabeled with 3S (lane a)
was added to interphase egg
extracts containing no nuclei
(lane c) or 1000 nuclei per ,ul
of extract and 100 ,ug/ml
aphidicolin (lane d). After a
30-min incubation, nickel-
IDA beads were added. The
complexes were isolated,
subjected to SDS gel electro-
phoresis, and either immu-
noblotted with anti-cyclin B
antibodies (top panel) or ex-
posed directly to a phosphor-
imaging screen for de-
tection of the 35S-labeled
Cdc2-AF protein. As a con-
trol (lane b), we added IDA
agarose beads lacking nickel
ions to an aliquot of the ex-
tract used in lane c. (C) The
purified Cdc2-AF/Acycin B
complex was added to inter-
phase egg extracts at a final
concentration of 4 nM (panel
a), 6 nM (panel b), or 8 nM
(panel c). The interphase ex-
tracts contained: 200 nuclei
per ,ll of extract (closed
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squares); 1000 nuclei per ,ul (closed triangles, in panel b only); or 1000 nuclei per ,ul and 100 ,ug/ml aphidicolin (closed circles). At the
indicated times, aliquots were removed, and nuclear envelope breakdown (NEB) was monitored by microscopy.
cles). As a control, we showed that even a twofold
higher concentration of Cdc2-AFA mutant complex
(20 nM) could not induce mitosis in cycloheximide-
containing extracts (closed squares), demonstrating
both that the mutant Cdc2 was indeed inactive and
that its bound Acyclin B partner could not activate
the normal, endogenous Cdc2 protein in the ex-
tracts. These experiments suggest that a titratable
inhibitor, which acts upon the Cdc2/cyclin B com-
plex, interferes with mitotic initiation when incom-
pletely replicated DNA is present. Further experi-
ments have indicated that this inhibitory activity
remains in the particulate fraction after isolation of
the soluble Cdc2-AF/cyclin B complex (our unpub-
lished observation), suggesting that the inhibitor
might be tightly associated with the nucleus.
DISCUSSION
In these studies, we have examined the regulation of
the Cdc2/cyclin B complex in Xenopus egg extracts,
which cannot enter mitosis in the presence of the
replication inhibitor aphidicolin (Dasso and Newport,
1990). This drug triggers the replication checkpoint, a
regulatory system of unknown nature that prevents
mitosis until the replication of the genome has reached
completion (Hartwell and Weinert, 1989; Dasso and
Newport, 1990). To study the mechanisms of this
checkpoint-induced arrest of the cell cycle, we estab-
lished an experimental system in which Xenopus ex-
tracts containing a recombinant Cdc2/cyclin B com-
plex cannot undergo mitosis in the presence of
aphidicolin. The cyclin subunit of the recombinant
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Figure 9. Characterization of the Cdc2-AF/Acyclin B complex in
aphidicolin-containing extracts. (A) The Cdc2-AF/Acyclin B com-
plex (6 nM) was added to interphase extracts containing: 1000 nuclei
per ,ul (closed squares); 1000 nuclei per ,ul and 100 jig/ml aphidi-
colin (open triangles); or 1000 nuclei per ,l, 100 ,ug/ml aphidicolin,
and 5 mM caffeine (open circles). At the indicated times, NEB in the
extracts was determined. (B) HI kinase activities of the Cdc2-AF/
Acyclin B complexes after re-isolation from interphase extracts. The
complex was isolated from the extracts with nickel-IDA after 15 min
(lanes d, f, and h) or 30 min (lanes e, g, and i) of incubation. The
interphase extracts contained: no nuclei (lanes a, d, and e); 1000
nuclei per Al and 100 ,ug/ml aphidicolin (lanes b, f, and g); or 1000
nuclei per ,ul, 100 ,g/ml aphidicolin, and 3 ,uM okadaic acid (lanes
c, h, and i). As a control, we demonstrated that there was no HI
kinase activity associated with nickel-IDA beads that had been
added to extracts that lacked the recombinant Cdc2/cyclin complex
(lanes a, b, and c).
Cdc2/cyclin B complex contains a six-histidine tag,
so it was possible to re-isolate the complex from
aphidicolin-treated extracts and biochemically char-
acterize its constituents under conditions in which
the extracts had remained stably arrested in inter-
phase. To aid in these experiments, we were able to
make use of a variety of Cdc2 mutants that contain
amino acid substitutions at key phosphorylation
sites. Thus, we could program the Xenopus extracts
to undergo mitotic-checkpoint regulation with
known amounts of a Cdc2/cyclin B complex of pre-
determined composition.
In cycling Xenopus extracts, newly synthesized cy-
clin B normally binds to Cdc2 and triggers the phos-
phorylation of Cdc2 on T161, Y15, and T14 (Solomon
et al., 1990). Later, one or more Cdc25 proteins gener-
ate active MPF by dephosphorylating Y15 and T14
(Galaktionov and Beach, 1991; Kumagai and Dunphy,
1991; Sebastian et al., 1993). It seemed plausible that






Figure 10. A complex between a triple-mutant Cdc2 protein
(T14AY15FT161A) and Acyclin B overcomes the aphidicolin-in-
duced blocks to mitosis. Except as indicated, the interphase extracts
lacked cycloheximide but contained 1000 nuclei per ,ul in the ab-
sence (closed triangles, open triangles, closed squares) or presence
(open circles, closed circles) of 100 ,ug/ml aphidicolin. The Cdc2-
T14AY15FT161A/Acyclin B complex was added to a final concen-
tration of either 10 nM (open triangles, open circles) or 20 nM
(closed squares). The incubation denoted by the closed squares
contained 100 ,tg/ml cycloheximide. NEB was quantitated at the
indicated times. T14AY15FT161A is abbreviated as AFA.
T14, or T161 might be modulated directly by unrepli-
cated DNA in checkpoint-arrested extracts. In the case
of phosphorylation at Y15, it is well established that
the experimental manipulation of the concentrations
of the Cdc25 and Weel proteins can alter the length of
interphase in both fission yeast and Xenopus extracts
(Russell and Nurse, 1986, 1987; Gautier et al., 1991;
Kumagai and Dunphy, 1991; Mueller et al., 1995).
Moreover, there is a report that aphidicolin induces an
increase of total Cdc2-specific tyrosine kinase activity
in Xenopus extracts (Smythe and Newport, 1992).
However, in our studies, we could not detect an
aphidicolin-dependent stimulation of Cdc2-specific
tyrosine kinase activity. One explanation for the dis-
crepancy might be that the GST-sea urchin cyclin B
that was utilized to form the tyrosine kinase substrate
in earlier studies can override the replication check-
point in a dominant manner (Kornbluth et al., 1992;
Smythe and Newport, 1992). Finally, in other studies,
we observed that aphidicolin did not increase the
activity of a recently cloned Xenopus Weel-like kinase
(Mueller et al., 1995). However, this observation does
not eliminate the possibility that Xenopus extracts
might contain additional Weel-like kinases that could
be regulated differently. The studies in this paper
show that total Cdc2-specific tyrosine kinase activity is
not modulated by the replication checkpoint.
We proceeded to analyze other enzymes that control
the phosphorylation of Cdc2. First, we corroborated
earlier results that indicated that the activity of the
Cdc25 protein, which dephosphorylates Y15 and most
probably T14, is not suppressed further below its nor-
mally low interphase levels by the presence of unrep-
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licated DNA (Izumi et al., 1992; Kumagai and Dunphy,
1992). Second, we could not detect an increase in
T14-specific kinase activity in aphidicolin-containing
extracts. Finally, the checkpoint did not appear to
affect T161 phosphorylation or dephosphorylation of
Cdc2, which is consistent with the fact that the Cdc2/
cyclin B complex that accumulates in aphidicolin-
treated extracts is fully phosphorylated on T161 (see
Figure 9).
These paradoxical results were clarified when we
observed that a Cdc2/cyclin B complex containing the
Cdc2-AF mutant (which cannot be phosphorylated on
Y15 or T14) displays an obvious reduction in its ability
to induce mitosis in aphidicolin-containing extracts.
This observation indicates that in the Xenopus system,
another inhibitory mechanism that does not involve
phosphorylation of Cdc2 on Y15 or T14 directs the
suppression of MPF in the presence of unreplicated
DNA. Obviously, it will be important to elucidate the
molecular identity of this inhibitory factor and the
mechanism by which unreplicated DNA controls its
action.
In the yeast systems, the role of tyrosine phosphor-
ylation in the replication checkpoint has been ana-
lyzed in a variety of genetic experiments. In the bud-
ding yeast S. cerevisiae, a strain harboring a mutant
Cdc2/CDC28 protein that cannot be phosphorylated
on either T18 or Y19 (the equivalents of T14 and Y15 in
fission yeast and frogs) displays no defects in the
replication checkpoint, and appears to grow normally
in all other respects (Amon et al., 1992; Sorger and
Murray, 1992; Booher et al., 1993; Stueland et al., 1993).
Moreover, Stueland et al. were able to demonstrate
that the Cdc2/cyclin B complex in budding yeast ar-
rested at the replication checkpoint was significantly
smaller during gel filtration than the complex from
control cells. These observations do not support the
notion that the replication checkpoint in budding
yeast operates exclusively through the inhibitory ty-
rosine and/or threonine phosphorylation of the
Cdc2/CDC28 protein.
However, studies in fission yeast have suggested a
different conclusion. Specifically, a fission yeast strain
containing mutations in both the weel and mikl genes
(whose products collaborate in the tyrosine phosphor-
ylation of Cdc2) cannot arrest its cell cycle in the
presence of the replication inhibitor hydroxyurea
(Lundgren et al., 1991). Intriguingly, single mutants in
either mikl or weel display an apparently normal rep-
lication checkpoint, even though weel mutants have
obvious defects in G2 size control (Enoch and Nurse,
1990; Lundgren et al., 1991; Rowley et al., 1992; Barbet
and Carr, 1993). Finally, a fission yeast strain contain-
ing a mutant Cdc2 that cannot be phosphorylated on
Y15 does not undergo a mitotic delay in the presence
of hydroxyurea (Gould and Nurse, 1989; Enoch et al.,
1991).
Our observations indicate that the replication check-
point in Xenopus extracts shares common features with
both the budding and fission yeast systems. On the
one hand, we found that Xenopus extracts containing
the Cdc2-AF mutant still undergo a pronounced mi-
totic delay in the presence of aphidicolin, which fits
well with the observations in the budding yeast sys-
tem. Conversely, the Xenopus extracts can tolerate only
limited amounts of the mutant Cdc2-AF complex; at
concentrations well above the threshold for mitotic
initiation in control extracts, this mutant complex in-
duces mitosis in the presence of aphidicolin, albeit
with delayed kinetics (see also Norbury et al., 1991).
As a result, the extracts enter mitosis inappropriately,
as is the case with fission yeast harboring the Y15F
mutant of the Cdc2 protein.
A plausible interpretation of these findings is that a
limiting inhibitor impedes the MPF-dependent induc-
tion of mitosis in the presence of unreplicated DNA. In
parallel, one or more Weel-like kinases, which are
highly active in interphase egg extracts, phosphorylate
Cdc2 on Y15 and T14, resulting in the formation of a
stably inactivated Cdc2/cyclin B complex. In this sce-
nario, the Cdc2-inhibitory tyrosine and threonine ki-
nases would not be regulated directly by the replica-
tion checkpoint. However, these kinases would play
an ancillary role in helping the checkpoint function
more efficiently by stably turning off the Cdc2/cyclin
B complex as its concentration increases throughout
interphase due to ongoing cyclin synthesis. In Xenopus
extracts, this back-up system appears to be important
because high concentrations of the Cdc2-AF protein
can override the replication checkpoint. It is possible
that a similar situation may exist in fission yeast. In
fission yeast, the replication checkpoint does not op-
erate effectively when tyrosine phosphorylation of
Cdc2 cannot occur, but conversely there is no evidence
that Cdc2-specific tyrosine kinase activity is modu-
lated by the presence of unreplicated DNA (Enoch and
Nurse, 1990; Lundgren et al., 1991; Rowley et al., 1992).
Finally, one might surmise that in budding yeast, the
back-up system afforded by Cdc2-specific tyrosine
phosphorylation is not essential.
Throughout this paper, we have addressed the
problem of how unreplicated DNA leads to the initial
suppression of the Cdc2/cyclin B complex. A related
issue is how the inactive Cdc2/cyclin B complex that
accumulates in interphase extracts containing unrep-
licated DNA eventually undergoes activation when
replication is complete. In principle, the mechanism
which impedes mitotic induction by the Cdc2-AF pro-
tein could be reversed at the end of S-phase. This
event could lead to the formation of a small amount of
active Cdc2, which has been hypothesized to be a
trigger for the activation of Cdc25 and inactivation of
Weel at mitosis (Solomon et al., 1990; Clarke et al.,
1993; Izumi and Maller, 1993; Dunphy, 1994; Lee et al.,
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1994). It is well established that the activation of Cdc25
and the inactivation of Weel at mitosis results from
the extensive phosphorylation of their regulatory do-
mains (reviewed in Dunphy, 1994). In the case of
Weel and Cdc25, multiple kinases most probably con-
tribute to this regulatory process, including Cdc2 and
another unidentified enzyme referred to as kinase X
(Tang et al., 1993; Kuang et al., 1994; Mueller et al.,
1995). It is not known whether kinase X is regulated by
Cdc2 or controlled independently. In the latter case, it
is conceivable that the completion of DNA replication
could trigger the activation of kinase X (or the inacti-
vation of a competing PP2A-like phosphatase). In this
scheme, although Cdc25 and Weel would not direct
the imposition of the checkpoint-dependent arrest of
interphase, these enzymes could play a role in receiv-
ing a signal for the completion of S-phase.
In conclusion, we have demonstrated that the check-
point-induced arrest of the Xenopus cell cycle in the
presence of unreplicated DNA does not operate prin-
cipally through the inhibitory tyrosine and threonine
phosphorylation of Cdc2 but instead involves a titrat-
able inhibitor of the Cdc2/cyclin B complex. The iden-
tification of this inhibitor and the elucidation of its
regulation will greatly expand our understanding of
the replication checkpoint.
ACKNOWLEDGMENTS
We thank our colleagues for comments on the manuscript. We are
grateful to D. Morgan (University of California, San Francisco) for
providing a baculovirus vector for histidine tagging. M. Solomon
(Yale University) kindly provided the Cdc2 mutant plasmids. This
work was supported by grants from the National Institutes of
Health, Lucille P. Markey Charitable Trust, National Science Foun-
dation, and Gustavus and Louise Pfeiffer Foundation. W.G.D. is an
investigator of the Howard Hughes Medical Institute.
REFERENCES
Amon, A., Surana, U., Muroff, I., and Nasmyth, K. (1992). Regula-
tion of p34CDC2S tyrosine phosphorylation is not required for entry
into mitosis in S. cerevisiae. Nature 355, 368-371.
Barbet, N.C., and Carr, A.M. (1993). Fission yeast weel protein-
kinase is not required for DNA damage-dependent mitotic arrest.
Nature 364, 824-827.
Booher, R.N., Deshaies, R.J., and Kirschner, M.W. (1993). Properties
of Saccharomyces cerevisiae weel and its differential regulation ofp34CDC28 in response to G1 and G2 cyclins. EMBO J. 12, 3417-3426.
Boyle, W.J., van der Geer, P., and Hunter, T. (1991). Phosphopeptide
mapping and phosphoamino acid analysis by two-dimensional sep-
aration on thin-layer cellulose plates. Methods Enzymol. 201, 110-
149.
Brown, A.J., Jones, T., and Shuttleworth, J. (1994). Expression and
activity of p40M`l5, the catalytic subunit of cdk-activating kinase,
during Xenopus oogenesis and embryogenesis. Mol. Biol. Cell 5,
921-932.
Clarke, P.R., Hoffmann, I., Draetta, G., and Karsenti, E. (1993).
Dephosphorylation of cdc25-C by a type-2A protein phosphatase:
specific regulation during the cell cycle in Xenopus egg extracts. Mol.
Biol. Cell 4, 397-411.
Coleman, T.R., Tang, Z., and Dunphy, W.G. (1993). Negative regu-
lation of the weel protein kinase by direct action of the niml /cdrl
mitotic inducer. Cell 72, 919-929.
Connell-Crowley, L., Solomon, M.J., Wei, N., and Harper, J.W.
(1993). Phosphorylation-independent activation of human cyclin-
dependent kinase 2 by cyclin A in vitro. Mol. Biol. Cell 4, 79-92.
Dasso, M., and Newport, J.W. (1990). Completion of DNA replica-
tion is monitored by a feedback system that controls the initiation of
mitosis in vitro: studies in Xenopus. Cell 61, 811-823.
Desai, D., Gu, Y., and Morgan, D.O. (1992). Activation of human
cycin-dependent kinases in vitro. Mol. Biol. Cell 3, 571-582.
Draetta, G. (1993). Cdc2 activation: the interplay of cyclin binding
and Thr161 phosphorylation. Trends Cell Biol. 3, 287-289.
Dunphy, W.G., and Newport, J.W. (1989). Fission yeast p13 blocks
mitotic activation and tyrosine dephosphorylation of the Xenopus
cdc2 protein kinase. Cell 58, 181-191.
Dunphy, W.G., and Kumagai, A. (1991). The cdc25 protein contains
an intrinsic phosphatase activity. Cell 67, 189-196.
Dunphy, W.G. (1994). The decision to enter mitosis. Trends Cell
Biol. 4, 202-207.
Enoch, T., and Nurse, P. (1990). Mutation of fission yeast cell cycle
control genes abolishes dependence of mitosis on DNA replication.
Cell 60, 665-673.
Enoch, T., Gould, K.L., and Nurse, P. (1991). Mitotic checkpoint
control in fission yeast. Cold Spring Harbor Symp. Quant. Biol. 56,
409-416.
Enoch, T., Carr, A.M., and Nurse, P. (1992). Fission yeast genes
involved in coupling mitosis to the completion of DNA replication.
Genes Devel. 6, 2035-2046.
Fleig, U.N., and Gould, K.L. (1991). Regulation of cdc2 activity in
Schizosaccharomyces pombe. Semin. Cell Biol. 2, 195-204.
Galaktionov, K., and Beach, D. (1991). Specific activation of cdc25
tyrosine phosphatases by B-type cyclins: evidence for multiple roles
of mitotic cyclins. Cell 67, 1181-1194.
Gautier, J., Solomon, M.J., Booher, R.N., Bazan, J.F., and Kirschner,
M.W. (1991). cdc25 is a specific tyrosine phosphatase that directly
activates p34cdc2. Cell 67, 197-211.
Glotzer, M., Murray, A.W., and Kirschner, M.W. (1991). Cyclin is
degraded by the ubiquitin pathway. Nature 349, 132-138.
Gould, K.L., and Nurse, P. (1989). Tyrosine phosphorylation of the
fission yeast cdc2+ protein kinase regulates entry into mitosis. Na-
ture 342, 39-45.
Hartwell, L., and Weinert, T. (1989). Checkpoints: controls that
ensure the order of cell cycle events. Science 246, 629-634.
Izumi, T., Walker, D.H., and Maller, J.L. (1992). Periodic changes in
phosphorylation of the Xenopus cdc25 phosphatase regulate its ac-
tivity. Mol. Biol. Cell 3, 927-939.
Izumi, T., and Maller, J.L. (1993). Elimination of cdc2 phosphoryla-
tion sites in the cdc25 phosphatase blocks initiation of M-phase.
Mol. Biol. Cell 4, 1337-1350.
Kobayashi, H., Minshull, J., Ford, C., Golsteyn, R., Poon, R., and
Hunt, T. (1991). On the synthesis and destruction of A- and B-type
cycins during oogenesis and meiotic maturation in Xenopus laevis. J.
Cell Biol. 114, 755-765.
Kornbluth, S., Smythe, C., and Newport, J.W. (1992). In vitro cell
cycle arrest induced by using artificial DNA templates. Mol. Cell.
Biol. 12, 3216-3223.
Molecular Biology of the Cell212
Checkpoint-regulated Inhibitor of Cdc2
Kornbluth, S., Sebastian, B., Hunter, T., and Newport, J. (1994).
Membrane localization of the kinase which phosphorylates p34cdc2
on threonine 14. Mol. Biol. Cell 5, 273-282.
Krek, W., and Nigg, E.A. (1991). Mutations of p34 cdc2 phosphor-
ylation sites induce premature mitotic events in HeLa cells; evi-
dence for a double block to p34 cdc2 kinase activation. EMBO J. 10,
305-316.
Kuang, J., Ashom, C.L., Gonzalez-Kuyvenhoven, M., and Penkala,
J.E. (1994). Cdc25 is one of the MPM-2 antigens involved in the
activation of maturation-promoting factor. Mol. Biol. Cell 5, 135-
145.
Kumagai, A., and Dunphy, W.G. (1991). The cdc25 protein controls
tyrosine dephosphorylation of the cdc2 protein in a cell-free system.
Cell 64, 903-914.
Kumagai, A., and Dunphy, W.G. (1992). Regulation of the cdc25
protein during the cell cycle in Xenopus extracts. Cell 70, 139-151.
Lee, T.H., Turck, C., and Kirschner, M.W. (1994). Inhibition of cdc2
activation by INH/PP2A. Mol. Biol. Cell 5, 323-338.
Lorca, T., Labb6, J.-C., Devault, A., Fesquet, D., Capony, J.-P., Ca-
vadore, J.-C., LeBouffant, F., and Doree, M. (1992). Dephosphoryla-
tion of cdc2 on threonine 161 is required for cdc2 kinase inactivation
and normal anaphase. EMBO J. 11, 2381-2390.
Lundgren, K., Walworth, N., Booher, R., Dembski, M., Kirschner,
M., and Beach, D. (1991). mikl and weel cooperate in the inhibitory
tyrosine phosphorylation of cdc2. Cell 64, 1111-1122.
McGowan, C.H., and Russell, P. (1993). Human weel kinase inhibits
cell-division by phosphorylating p34cdc2 exclusively on tyrl5.
EMBO J. 12, 75-85.
Milarski, K.L., Dunphy, W.G., Russell, P., Gould, S.J., and Newport,
J.W. (1991). Cloning and characterization of Xenopus cdc2, a com-
ponent of MPF. Cold Spring Harbor Symp. Quant. Biol. 56,377-384.
Morla, A.O., Draetta, G., Beach, D., and Wang, J.Y.J. (1989). Revers-
ible tyrosine phosphorylation of cdc2: dephosphorylation accompa-
nies activation during entry into mitosis. Cell 58, 193-203.
Mueller, P.R., Coleman, T.R., and Dunphy, W.G. (1995). Cell cycle
regulation of a Xenopus weel-like kinase. Mol. Biol. Cell 6, 119-134.
Murray, A.W., and Kirschner, M.W. (1989). Cyclin synthesis drives
the early embryonic cell cycle. Nature 339, 275-280.
Murray, A.W. (1991). Cell-cycle extracts. Methods Cell Biol. 36,
581-605.
Murray, A.W. (1992). Creative blocks: cell-cycle checkpoints and
feedback controls. Nature 359, 599-604.
Nigg, E.A. (1993). Cellular substrates of p34cdc2 and its companion
cyclin-dependent kinases. Trends Cell Biol. 3, 296-301.
Norbury, C., Blow, J., and Nurse, P. (1991). Regulatory phosphory-
lation of p34 cdc2 protein kinase in vertebrates. EMBO J. 10, 3321-
3329.
Vol. 6, February 1995
Nurse, P. (1990). Universal control mechanism regulating onset of
M-phase. Nature 344, 503-508.
Parker, L., and Piwnica-Worms, H. (1992). Inactivation of the
p34cdc2_cyclin-B complex by the human weel tyrosine kinase. Sci-
ence 257, 1955-1957.
Pines, J., and Hunter, T. (1989). Isolation of a human cyclin cDNA:
evidence for cyclin mRNA and protein regulation in the cell cycle
and for interaction with p34cdc2. Cell 58, 833-846.
Pines, J. (1993). Arresting developments in cell cycle control. Trends
Biochem. Sci. 18, 195-197.
Rowley, R., Hudson, J., and Young, P.G. (1992). The weel protein
kinase is required for radiation-induced mitotic delay. Nature 356,
353-355.
Russell, P., and Nurse, P. (1986). cdc25+ functions as an inducer in
the mitotic control of fission yeast. Cell 45, 145-153.
Russell, P., and Nurse, P. (1987). Negative regulation of mitosis by
weel +, a gene encoding a protein kinase homolog. Cell 49, 559-567.
Sebastian, B., Kakizuka, A., and Hunter, T. (1993). Cdc25M2 activa-
tion of cyclin-dependent kinases by dephosphorylation of threo-
nine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA 90, 3521-3524.
Schlegel, R., and Pardee, A. (1987). Periodic mitotic events induced
in the absence of DNA replication. Proc. Natl. Acad. Sci. USA 84,
9025-9029.
Sheldrick, K.S., and Carr, A.M. (1993). Feedback controls and G2
checkpoints: fission yeast as a model system. BioEssays 15, 775-782.
Smythe, C., and Newport, J.W. (1992). Coupling of mitosis to the
completion of S phase in Xenopus occurs via modulation of the
tyrosine kinase that phosphorylates p34cdc2. Cell 68, 787-797.
Solomon, M.J., Glotzer, M., Lee, T.H., Philippe, M., and Kirschner,
M.W. (1990). Cyclin activation of p34dC2. Cell 63, 1013-1024.
Solomon, M.J., Lee, T., and Kirschner, M.W. (1992). Role of phos-
phorylation in p34Cdc2 activation: identification of an activating ki-
nase. Mol. Biol. Cell 3, 13-27.
Solomon, M.J. (1993). Activation of various cyclin/cdc2 protein
kinases. Curr. Opin. Cell Biol. 5, 180-186.
Sorger, P.K., and Murray, A.W. (1992). S-phase feedback control in
budding yeast independent of tyrosine phosphorylation of
p34CDC28 . Nature 355, 365-368.
Stueland, C.S., Lew, D.J., Cismowski, M.J., and Reed, S.I. (1993). Full
activation of p34CDC28 histone HI kinase activity is unable to pro-
mote entry into mitosis in checkpoint-arrested cells of the yeast
Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 3744-3755.
Tang, Z., Coleman, T.R., and Dunphy, W.G. (1993). Two distinct
mechanisms for negative regulation of the weel protein kinase.
EMBO J. 12, 3427-3436.
213
